SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-207797
Filing Date
2022-08-01
Accepted
2022-08-01 08:10:59
Documents
5
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d386559d6k.htm 6-K 11398
2 EX-99.1 d386559dex991.htm EX-99.1 8110
3 GRAPHIC g386559dsp5.jpg GRAPHIC 2750
4 GRAPHIC g386559g0730232632244.jpg GRAPHIC 4996
5 GRAPHIC g386559g0730232632556.jpg GRAPHIC 2881
  Complete submission text file 0001193125-22-207797.txt   35795
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 221122856
SIC: 2834 Pharmaceutical Preparations